Siren, L.L.C. has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2 Trillion distributed in 112 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $141B, Bei Gene, Ltd. with a value of $126B, Scholar Rock Holding Corp with a value of $90.2B, Bicara Therapeutics Inc with a value of $78.3B, and Argenx Se with a value of $77.9B.

Examining the 13F form we can see an increase of $2T in the current position value.

Siren, L.L.C. is based out at New York, NY

Below you can find more details about Siren, L.L.C. portfolio as well as his latest detailed transactions.

Portfolio value $2 Trillion
Technology: $56.7 Billion
Communication Services: $43.2 Billion
Consumer Cyclical: $15.5 Billion
Healthcare: $7.54 Billion
Financial Services: $5.81 Billion
Consumer Defensive: $3.62 Billion
Real Estate: $1.99 Billion
Energy: $1.8 Billion
Other: $434 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 112
  • Current Value $2 Trillion
  • Filing
  • Period Q3 2024
  • Filing Date November 13, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 109 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Siren, L.L.C. Portfolio

Follow Siren, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siren, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Siren, L.L.C. with notifications on news.